Dynasty Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Dynasty Wealth Management's VRTX Position: Q2 2026 in Review
Dynasty Wealth Management reduced its Vertex Pharmaceuticals (VRTX) stake by 21% in Q2 2026, selling an estimated $95.7K and leaving 833 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #282.
Dynasty Wealth Management first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $468K in Q1 2026. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Dynasty Wealth Management held 833 shares of Vertex Pharmaceuticals worth $414K as of Q2 2026.
- Dynasty Wealth Management sold 216 Vertex Pharmaceuticals shares in Q2 2026, an estimated $95.7K.
- Vertex Pharmaceuticals made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #282 holding.
- Dynasty Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Dynasty Wealth Management's Vertex Pharmaceuticals position peaked at $468K in Q1 2026.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.